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antigastric parietal cell antibody; desquamative gingivitis; macrocytosis; oral lichen planus; pernicious anemia; vitamin B12 deficiency Background/purpose: Erosive oral lichen planus (EOLP) patients with desquamative gingivitis (DG) are sometimes encountered in our oral mucosal disease clinic. This study assessed hematinic deficiencies and anemia statuses in antigastric parietal cell antibody (GPCA)-positive EOLP patients with DG (GPCA þ /DG þ /EOLP patients). Methods: The blood hemoglobin, iron, vitamin B12, folic acid, and homocysteine concentrations and serum GPCA levels in 92 GPCA þ /DG þ /EOLP patients and 184 age-and sex-matched healthy controls were measured and compared between the two groups. Results: We found that 27 (29.3%), 16 (17.4%), and 27 (29.3%) of 92 GPCA þ /DG þ /EOLP patients had hemoglobin (men < 13 g/dL and women < 12 g/dL), iron (< 60 mg/dL), and vitamin B12 (< 200 pg/mL) deficiencies, respectively. Moreover, 37 (40.2%) of 92 GPCA þ /DG þ /EOLP patients had an abnormally high blood homocysteine level (> 12.1mM). GPCA þ /DG þ /EOLP patients had a significantly higher frequency of hemoglobin, iron, or vitamin B12 deficiency and an abnormally high blood homocysteine level than healthy control individuals (all p < 0.001). Of 27 anemic GPCA þ /DG þ /EOLP patients, 13 (48.2%) had pernicious anemia, five (18.5%) had iron deficiency anemia, one (3.7%) had thalassemia trait, and the remaining eight (29.6%) had normocytic anemia. Moreover, of the 92 GPCA þ /DG þ /EOLP patients, 24 had macrocytosis, and only 13 (54.2%) of these 24 patients had pernicious anemia.
Conclusion:
We conclude that GPCA þ /DG
Introduction
Desquamative gingivitis (DG) presents mainly as painful erosions or ulcerations of the attached and free gingivae. It is now recognized to be a manifestation of several diseases, principally mucocutaneous autoimmune disorders such as oral lichen planus (OLP), mucous membrane pemphigoid, and pemphigus vulgaris. 1e3 Our recent study found that 455 (91%), 40 (8%), and five (1%) of 500 DG patients were associated with erosive oral lichen planus (EOLP), pemphigus vulgaris, and mucous membrane pemphigoid, respectively. 4 Our previous study found that 84 (26.3%) of 320 OLP patients were antigastric parietal cell antibody (anti-GPCA) positive. 5 Our recent study also showed a GPCA-positive rate of 39.6% in 455 EOLP patients with DG (DG þ /EOLP patients). 4 The GPCA may induce destruction of gastric parietal cells and, in turn, result in failure of intrinsic factor production. 6, 7 A lack of intrinsic factor may lead to vitamin B12 deficiency. Vitamin B12 plays an important role in hemoglobin (Hb) and DNA synthesis and cell division. Patients with vitamin B12 deficiency may have Hb deficiency and macrocytosis [mean corpuscular volume or (MCV) ! 100 fL] that finally causes pernicious anemia. 8, 9 Vitamin B12 deficiency may also be due to an inadequate intake of vitamin B12-containing foods, vitamin B12 malabsorption, biologic competition including bacterial overgrowth and tapeworm infestation, and transcobalamin II deficiency. 9 As multiple causes are involved in vitamin B12 deficiency and macrocytosis, it is interesting to know the frequencies of vitamin B12 deficiency, macrocytosis, and macrocytic anemia in
Our previous studies demonstrated that some patients with oral mucosal diseases such as OLP, burning mouth syndrome, and atrophic glossitis may have autoantibodies in their sera. Thus, we frequently examined the presence of different types of autoantibodies such as GPCA, antithyroglobulin antibody (anti-TGA), and antithyroid microsomal antibody (anti-TMA, also known as antithyroid peroxidase antibody) in the sera of oral mucosal disease patients, especially the DG þ /EOLP patients. 4,5,10e16 In this study, we recruited 92 GPCA þ /DG þ /EOLP patients from the oral mucosal disease clinic of National Taiwan University Hospital (NTUH). For these GPCA þ /DG þ /EOLP patients, complete blood count, serum iron, vitamin B12, folic acid, homocysteine, TGA, and TMA levels were checked to assess whether these patients had microcytic, normocytic, or macrocytic anemia; thalassemia; deficiencies of hematinics; and serum TGA or TMA positivity. These data were further compared with the corresponding data of 184 ageand sex-matched healthy control individuals without oral mucosal and systemic diseases to evaluate whether GPCA þ / DG þ /EOLP patients had higher frequencies of anemia, vitamin B12 deficiency, macrocytosis (MCV ! 100 fL), abnormally high blood homocysteine level, and TGA or TMA positivity than with healthy control individuals.
Materials and methods

Patients
In this study, 92 (14 men and 78 women, age range 29e87 years, mean age 58 AE 12 years) GPCA þ /DG þ /EOLP patients were enrolled. For each GPCA þ /DG þ /EOLP patient, two age-(AE2 years of each patient's age) and sexmatched healthy control individuals were selected. Thus, the normal control group consisted of 184 healthy individuals (28 men and 156 women, age range 29e87 years, mean age 57 AE 11 years). All the patients and healthy control individuals who were seen consecutively, diagnosed, and treated in the oral mucosal disease clinic of NTUH from July 2007 to May 2015 were selected for the study. DG was diagnosed when patients had painful erythematous lesions, erosions, or ulcerations on at least one-quarter of the total maxillary and mandibular gingivae.
1,2 OLP was diagnosed according to the criteria described previously. 5, 16 However, all GPCA þ /DG þ /EOLP patients with areca quid chewing habit, autoimmune diseases (such as systemic lupus erythematosus, rheumatoid arthritis, Sjogren's syndrome, pemphigus vulgaris, and cicatricial pemphigoid), inflammatory diseases, recurrent aphthous ulcerations, malignancy, or recent surgery were excluded. In addition, all GPCA þ /DG þ /EOLP patients with serum creatinine concentrations indicative of renal dysfunction (men > 131mM, women > 115mM) and those who reported a history of stroke, heavy alcohol use, or diseases of the liver, kidney, or coronary arteries were also excluded. 17 Healthy control individuals had dental caries, pulpal disease, malocclusion, or missing of teeth, but did not have any oral mucosal or systemic diseases. None of our GPCA þ /DG þ /EOLP patients had taken any prescription medication for malignancies, epilepsy, diabetes mellitus, infection, inflammation, DG, or EOLP at least 3 months before entering the study.
The blood samples were drawn from all GPCA þ /DG þ / EOLP patients and healthy control individuals for measurement of complete blood count, blood iron, vitamin B12, folic acid, and homocysteine concentrations, as well as serum GPCA, TGA, and TMA levels. All the patients and healthy control individuals signed the informed consent forms before entering the study. This study was reviewed and approved by the Institutional Review Board of NTUH.
Determination of complete blood count and blood iron, vitamin B12, folic acid, and homocysteine concentrations
Complete blood count and blood iron, vitamin B12, folic acid, and homocysteine concentrations were determined with routine tests performed in the Department of Laboratory Medicine of NTUH as described previously.
10e16
Determination of serum anti-GPCA level
The serum GPCA level was detected using the indirect immunofluorescence technique with rat stomach as a substrate, as described previously.
5,10e13 Sera were scored as positive when they produced fluorescence at a dilution of 10-fold or more.
Determination of serum anti-TGA or anti-TMA level TGA and TMA titers were measured by a semiquantitative microtiter particle agglutination test using Serodia-AMC kits (Fujirebio Inc., Tokyo, Japan), as described previously. 5, 12 Serum TGA or TMA titers equal to or greater than 1:40 were considered positive.
Statistical analysis
Comparisons of the MCV and the mean blood levels of Hb, iron, vitamin B12, folic acid, and homocysteine between 92 GPCA þ /DG þ /EOLP patients and 184 age-and sex-matched healthy control individuals were performed using the Student t test. The differences in the frequency of Hb, iron, vitamin B12, or folic acid deficiency; abnormally high blood homocysteine level; or serum TGA or TMA positivity between 92 GPCA þ /DG þ /EOLP patients and 184 age-and sexmatched healthy control individuals were compared using the Chi-square test. Comparisons of the MCV; mean blood concentrations of Hb, iron, vitamin B12, folic acid, and homocysteine; and serum TGA or TMA positivity between any two of the three groups of patients with macrocytic, normocytic, or microcytic red blood cells (RBCs) were performed using Student t test or Chi-square test where appropriate. The result was considered to be significant when p < 0.05.
Results
The MCV and mean blood concentrations of Hb, iron, vitamin B12, folic acid, and homocysteine in 92 GPCA þ / DG þ /EOLP patients and 184 age-and sex-matched healthy control individuals are shown in Table 1 . As men usually have higher blood levels of Hb and iron than women, these two mean levels were calculated separately for men and women. We found significantly lower mean Hb (for both men and women; p < 0.001 for both), iron (for women only; p < 0.001), and vitamin B12 (p < 0.001) levels as, well as a significantly higher mean blood homocysteine level (p < 0.001) in GPCA þ /DG þ /EOLP patients than in healthy control individuals (Table 1) .
According to the World Health Organization (WHO) criteria, men with Hb < 13 g/dL and women with Hb < 12 g/ dL were defined as having Hb deficiency or anemia. 18, 19 Furthermore, patients with a serum iron level of < 60 mg/ dL, 20 a vitamin B12 level of < 200 pg/mL, 17 or a folic acid level of < 4 ng/mL 21 were defined as having iron, vitamin B12, or folic acid deficiency, respectively. Moreover, patients with a blood homocysteine level of > 12.1mM (which was the mean blood homocysteine level of healthy control individuals plus two standard deviations) were defined as having an abnormally high homocysteine level. According to the abovementioned definitions, 27 (29.3%), 16 (Table 2 ). However, none of the normal control individuals was diagnosed as having Hb, iron, vitamin B12, and folic acid deficiencies according to the aforementioned strict WHO criteria. However, a high blood homocysteine level (> 12.1mM), serum TGA positivity, and serum TMA positivity were found in eight (4.3%), three (1.6%), and three (1.6%) normal control individuals, respectively. GPCA þ /DG þ /EOLP patients had a significantly higher frequency of Hb, iron, or vitamin B12 deficiency; abnormally high blood homocysteine level; and serum TGA or TMA positivity than healthy control individuals (all p < 0.001; Table 2 ).
In this study, 27 (29.3%) GPCA þ /DG þ /EOLP patients were diagnosed as having anemia according to the WHO criteria. 18 Considering the diagnostic criteria for pernicious anemia as having MCV ! 100 fL, vitamin B12 < 200 pg/mL, and serum GPCA positivity; 13 iron deficiency anemia as having MCV < 80 fL and iron < 60 mg/dL; 19, 20 and thalassemia trait as having MCV < 74 fL, RBC count > 5.0 Â 10 12 / L, and Mentzer index (MCV/RBC) < 13, 22 we found that of 27 anemic GPCA þ /DG þ /EOLP patients, 13 had pernicious anemia, five had iron deficiency anemia, one had thalassemia trait, and the remaining eight had normocytic anemia (Table 3) .
When 92 GPCA þ /DG þ /EOLP patients were further divided into three groups, Group 1 (24 patients with MCV ! 100 fL), Group 2 (61 patients with MCV between 80 fL and 99.9 fL), and Group 3 (seven patients with MCV < 80 fL), we found that Group 1 patients had significantly higher MCV (p < 0.001), a lower mean Hb level (for both men and women; men, p Z 0.001; women, p Z 0.003), a lower mean serum iron level (for men only; p Z 0.012), a lower mean serum vitamin B12 level (p < 0.001), and a higher mean serum homocysteine level (p < 0.001) than Group 2 patients (Table 4) . Moreover, Group 3 patients had a significantly lower mean Hb level (for women only; p < 0.001), lower MCV (p < 0.001), a lower mean serum iron level (for women only; p Z 0.003), and a lower mean vitamin B12 level (p Z 0.035) than Group 2 patients (Table 4 ). In addition, Group 1 patients had significantly higher MCV (p < 0.001), a higher mean Hb level (for women only; p Z 0.029), a higher mean serum iron level (for women only; p Z 0.001), and a lower mean serum vitamin B12 level (p < 0.001) than Group 3 patients (Table 4) .
Discussion
This study found that of the 92 GPCA þ /DG þ /EOLP patients, 24 produced macrocytic RBCs, 61 normocytic RBCs, and seven microcytic RBCs. Moreover, 27 (29.3%) of the 92 
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þ /EOLP patients, 13 had macrocytic anemia (MCV ! 100 fL; all had pernicious anemia including three having concomitant iron deficiency), 13, 14 six had microcytic anemia (MCV < 80 fL; five had iron deficiency anemia and one had thalassemia trait), 19, 22 and eight had normocytic anemia (MCV between 80 fL and 99.9 fL; including three having concomitant iron deficiency). As GPCA may induce destruction of gastric parietal cells and further result in failure of intrinsic factor production, GPCA þ /DG þ /EOLP patients are supposed to have vitamin B12 deficiency, which in turn results in the generation of macrocytic RBCs and pernicious anemia. 13, 14 However, we showed that only 27 (29.3%), 24 (26.1%), and 13 (14.1%) of 92 GPCA þ /DG þ /EOLP patients had vitamin B12 deficiency, macrocytosis, and pernicious anemia, respectively. We also found that 13 (48.1%) of our 27 vitamin B12 deficiency patients and 13 (54.2%) of our 24 macrocytosis patients had pernicious anemia. Our previous studies demonstrated that 16 (12 This study found microcytosis in seven GPCA þ /DG þ / EOLP patients. Of these seven microcytosis patients, five had iron deficiency anemia including three having concomitant vitamin B12 deficiency and an abnormally high serum homocysteine level, one had thalassemia trait, and the remaining one had normal Hb, vitamin B12, folic acid, and iron levels. The five anemic microcytosis patients had severe iron deficiency (serum iron level < 35 mg/dL). The severe iron deficiency may play an important role in the generation of microcytic RBCs in these five anemic microcytosis patients. In addition, vitamin B12 deficiency may be the predominant factor that results in an abnormally high serum homocysteine level in patients, 14 and both iron and vitamin B12 deficiencies may be the factors causing anemia in these five anemic microcytosis patients. 14, 19 In the present study, 61 of 92 GPCA þ /DG þ /EOLP patients had normocytosis. Of these 61 normocytosis patients, eight had normocytic anemia with three having concomitant iron deficiency, seven had iron deficiency (six with serum iron levels between 48 mg/dL and 59 mg/dL; one with a serum iron level of 33 mg/dL), and none had vitamin B12 and folic acid deficiencies. The normal vitamin B12 and folic acid Even when intrinsic factor is not present to aid the absorption of vitamin B12 or in other diseases that affect the usual absorption sites in the terminal ileum, oral therapy with vitamin B12 remains effective. 9 Therefore, although GPCA þ /DG þ /EOLP patients have GPCA in their sera, enough dietary supply of vitamin B12 may prevent the occurrence of vitamin B12 deficiency in these patients. In addition, those GPCA-positive patients require a sufficiently long period of time to develop autoimmune gastritis, which finally results in complete failure of intrinsic factor production. 8, 23 Therefore, the residual gastric parietal cells of patients with lower serum titer of GPCA, or those with medium or higher serum titer of GPCA of a shorter duration may still have some ability to produce intrinsic factors that help absorb vitamin B12 from the small intestine.
Carrozzo et al 24 discovered the presence of serum GPCA in three (6%) and antithyroid antibodies in five (10%) of 50 OLP patients. Our previous study demonstrated that 84 (26.3%), 68 (21.3%), and 78 (24.4%) of 320 OLP patients had GPCA, TGA, and TMA positivities, respectively. 4, 5, 24 Further studies are necessary to confirm this intimate association.
Homocysteine is a sulfur-containing amino acid that is formed during methionine metabolism. 25 Both vitamin B12 and folic acid act as coenzymes for the conversion of homocysteine to methionine. 26 Higher blood homocysteine levels can cause oxidative stress, damage endothelium, and enhance thrombogenicity in experimental studies, and thus are associated with increased rates of coronary heart disease and stroke. 25,27e30 Moreover, measurement of both serum methylmalonic acid and homocysteine levels has been discovered to be a more sensitive method of screening for vitamin B12 deficiency, with the sensitivity being 99.8%, and thus can be used for detecting subclinical vitamin B12 deficiency. 9, 31 In this study, an abnormally higher blood homocysteine level was detected in 37 (40.2%) of the 92 GPCA þ /DG þ /EOLP patients, but could be found in only eight (4.3%) of the 184 healthy control individuals. Previous studies demonstrated that the high blood homocysteine level found in patients is due to deficiencies in folic acid, vitamin B12, and vitamin B6, because a supplement therapy with folic acid, vitamin B12, and vitamin B6 can reduce their blood homocysteine levels. 28, 32, 33 In this study, of 37 patients with abnormally higher blood homocysteine levels, 24 (64.9%) had vitamin B12 deficiency according to the WHO definition (vitamin B12 level < 200 pg/mL) 17 and 32 (86.5%) had relative vitamin B12 deficiency according to our previous definition (vitamin B12 level 450 pg/mL). 32, 33 Furthermore, of our 37 patients with abnormally higher blood homocysteine levels, none had folic acid deficiency according to the WHO definition (folic acid level < 4 ng/ mL) 21 and only five (13.5%) had relative folic acid deficiency according to our previous definition (folic acid level 6 ng/ mL). 32, 33 Moreover, our 92 GPCA þ /DG þ /EOLP patients also had a significantly lower mean serum vitamin B12 level than healthy control individuals. Therefore, the high blood homocysteine level in our 92 GPCA þ /DG þ /EOLP patients may predominantly be due to vitamin B12 deficiency rather than folic acid deficiency.
Our results demonstrated that, according to WHO definitions, 27 (29.3%), 16 (17.4%), and 27 (29.3%) of 92 GPCA þ / DG þ /EOLP patients had Hb, iron, and vitamin B12 deficiencies, respectively. Moreover, 37 (40.2%), 26 (28.3%), and 35 (38.0%) of our 92 GPCA þ /DG þ /EOLP patients had an abnormally high blood homocysteine level, serum TGA positivity, and serum TMA positivity, respectively. GPCA þ / DG þ /EOLP patients had a significantly higher frequency of Hb, iron, or vitamin B12 deficiency; abnormally high blood homocysteine level; and serum TGA or TMA positivity than healthy control individuals. Of 27 anemic GPCA þ /DG þ / EOLP patients, 13 had pernicious anemia, five had iron deficiency anemia, one had thalassemia trait, and the remaining eight had normocytic anemia. Moreover, of the 92 GPCA þ /DG þ /EOLP patients, 24 had macrocytosis, and only 13 of these 24 macrocytosis patients had pernicious anemia. We conclude that GPCA þ /DG þ /EOLP patients have a significantly higher frequency of iron and vitamin B12 deficiencies, abnormally high blood homocysteine level, and serum TGA or TMA positivity than healthy control individuals. In addition to pernicious anemia (14.1%), GPCA þ / DG þ /EOLP patients may have normocytic anemia (8.7%) or microcytic anemia (6.5%).
